CAR T-cell therapy Market Overview and Analysis:
The global CAR T-cell therapy market size was evaluated at USD 3.82 billion in 2022, registering a CAGR of 29.8% from 2023 to 2030.
Chimeric antigen receptor (CAR) T-cell therapy is a new type of cancer treatment, in which healthcare professionals change to T-cells in the lab and then infuse them into the body of a cancer patient, so they can find and destroy cancer cells. CAR T-cell therapy is a method of training the immune system to recognize cancerous cells.
get more info @ https://www.datalibraryresearc....h.com/market-analysi
Харесвам
Коментирай
Сподели
